EXAR CORP
PRES14A, 2000-04-28
SEMICONDUCTORS & RELATED DEVICES
Previous: LEXINGTON SILVER FUND INC, 485BPOS, 2000-04-28
Next: MANUFACTURERS LIFE INSURANCE CO OF NORTH AMERICA SEP ACC A, 485BPOS, 2000-04-28



<PAGE>

                            SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant                     /X/
Filed by a Party other than the Registrant  / /

Check the appropriate box:

/X/  Preliminary Proxy Statement
/ /  Confidential, for Use of the Commission Only (as permitted
     by Rule 14a-6(e)(2))
/ /  Definitive Proxy Statement
/ /  Definitive Additional Materials
/ /  Soliciting Material Pursuant to Section 240.14a-11(c) or Section 240.14a-12

                                EXAR CORPORATION
                (Name of Registrant as Specified In Its Charter)

Payment of Filing Fee (Check the appropriate box)

/X/  No fee required.
/ /  $500 per each party to the controversy pursuant to Exchange Act Rule
     14a-6(i)(3).
/ /  Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.

     1. Title of each class of securities to which transaction applies:

        -----------------------------------------------------------------------

     2. Aggregate number of securities to which transaction applies:

        -----------------------------------------------------------------------

     3. Per unit price or other underlying value of transaction computed
        pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the
        filing fee is calculated and state how it was determined):

        -----------------------------------------------------------------------

     4. Proposed maximum aggregate value of transaction:

        -----------------------------------------------------------------------

     5. Total fee paid:

        -----------------------------------------------------------------------

/ /  Fee paid previously with preliminary materials.

/ /  Check box if any part of the fee is offset as provided by Exchange Act
     Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
     paid previously. Identify the previous filing by registration statement
     number, or the Form or Schedule and the date of its filing.

     1. Amount Previously Paid:

        -----------------------------------------------------------------------

     2. Form, Schedule or Registration Statement No.:

        -----------------------------------------------------------------------

     3. Filing Party:

        -----------------------------------------------------------------------

     4. Date Filed:


<PAGE>

                                      LOGO

                    NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
                           TO BE HELD ON JUNE 8, 2000

TO THE STOCKHOLDERS OF EXAR CORPORATION:

     NOTICE IS HEREBY GIVEN that a Special Meeting of Stockholders of EXAR
CORPORATION, a Delaware corporation (the "Company"), will be held on June 8,
2000 at 3:00 p.m. local time at the Company's principal executive offices at
48720 Kato Road, Fremont, CA 94538 to act on the following matter:

     1.   To approve an amendment to the Company's Amended and Restated
          Certificate of Incorporation to increase the authorized number of
          shares of Common Stock from 25,000,000 shares to 100,000,000 shares.

     The foregoing item of business is more fully described in the Proxy
Statement accompanying this Notice.

     The Board of Directors has fixed the close of business on April 28, 2000 as
the record date for the determination of stockholders entitled to notice of and
to vote at this Special Meeting and at any adjournment or postponement thereof.

                                           By Order of the Board of Directors

                                           Donald L. Ciffone, Jr.
                                           PRESIDENT AND CHIEF EXECUTIVE OFFICER

Fremont, California
May __, 2000

     ALL STOCKHOLDERS ARE CORDIALLY INVITED TO ATTEND THE MEETING IN PERSON.
WHETHER OR NOT YOU EXPECT TO ATTEND THE MEETING, PLEASE COMPLETE, DATE, SIGN AND
RETURN THE ENCLOSED PROXY AS PROMPTLY AS POSSIBLE IN ORDER TO ENSURE YOUR
REPRESENTATION AT THE MEETING. A RETURN ENVELOPE (WHICH IS POSTAGE PREPAID IF
MAILED IN THE UNITED STATES) IS ENCLOSED FOR THAT PURPOSE. EVEN IF YOU HAVE
GIVEN YOUR PROXY, YOU MAY STILL VOTE IN PERSON IF YOU ATTEND THE MEETING. PLEASE
NOTE, HOWEVER, THAT IF YOUR SHARES ARE HELD OF RECORD BY A BROKER, BANK OR OTHER
NOMINEE AND YOU WISH TO VOTE AT THE MEETING, YOU MUST OBTAIN FROM THE RECORD
HOLDER A PROXY ISSUED IN YOUR NAME.


<PAGE>


                                      LOGO

                                 PROXY STATEMENT
                       FOR SPECIAL MEETING OF STOCKHOLDERS

                                   TO BE HELD
                                  JUNE 8, 2000

                 INFORMATION CONCERNING SOLICITATION AND VOTING

GENERAL

     The enclosed proxy is solicited on behalf of the Board of Directors of
Exar Corporation, a Delaware corporation (the "Company"), for use at the
Special Meeting of Stockholders to be held on June 8, 2000 at 3:00 p.m. local
time (the "Special Meeting"), or at any adjournment or postponement thereof,
for the purpose set forth herein and in the accompanying Notice of Special
Meeting. The Special Meeting will be held at the Company's principal
executive offices located at 48720 Kato Road, Fremont, California 94538. The
Company intends to mail this proxy statement and accompanying proxy card on
or about May 8, 2000 to all stockholders entitled to vote at the Special
Meeting.

SOLICITATION

     The Company will bear the entire cost of solicitation of proxies,
including preparation, assembly, printing and mailing of this proxy
statement, the proxy and any additional information furnished to
stockholders. Copies of solicitation materials will be furnished to banks,
brokerage houses, fiduciaries and custodians holding in their names shares of
Common Stock beneficially owned by others to forward to such beneficial
owners. The Company may reimburse persons representing beneficial owners of
Common Stock for their costs of forwarding solicitation materials to such
beneficial owners. Original solicitation of proxies by mail may be
supplemented by telephone, telegram or personal solicitation by directors,
officers or other regular employees of the Company or, at the Company's
request. No additional compensation will be paid to directors, officers or
other regular employees for such services, but a third-party proxy solicitor
to be determined by the Company will be paid its customary fee, estimated to
be about $4,500, if it renders solicitation services.

VOTING RIGHTS AND OUTSTANDING SHARES

     Only holders of record of Common Stock at the close of business on April
28, 2000 (the "Record Date") will be entitled to notice of and to vote at the
Special Meeting. On the Record Date, the Company had 18,615,969 shares of
Common Stock outstanding and entitled to vote.

     Each holder of record of Common Stock on such date will be entitled to
one vote for each share held on the matter to be voted upon at the Special
Meeting.

     All votes will be tabulated by the inspector of election appointed for
the meeting, who will separately tabulate affirmative and negative votes,
abstentions and broker non-votes. The affirmative vote of a majority of the
outstanding shares of Common Stock is required to approve Proposal 1 to be
voted on at the Special Meeting. For purposes of Proposal 1, abstentions and
broker non-votes will have the same effect as negative votes.

<PAGE>

REVOCABILITY OF PROXIES

     Any person giving a proxy pursuant to this solicitation has the power to
revoke it at any time before it is voted. It may be revoked by filing with
the Secretary of the Company at the Company's principal executive office,
48720 Kato Road, Fremont, California 94538, a written notice of revocation or
a duly executed proxy bearing a later date, or it may be revoked by attending
the meeting and voting in person. Attendance at the meeting will not, by
itself, revoke a proxy.

                                   PROPOSAL 1

                  APPROVAL OF INCREASE IN NUMBER OF AUTHORIZED
                             SHARES OF COMMON STOCK

     The Board of Directors has adopted, subject to stockholder approval, an
amendment to the Company's Amended and Restated Certificate of Incorporation
to increase the Company's authorized number of shares of Common Stock from
25,000,000 shares to 100,000,000 shares.

     The additional Common Stock to be authorized by adoption of the
amendment would have rights identical to the currently outstanding Common
Stock of the Company. Adoption of the proposed amendment and issuance of the
Common Stock would not affect the rights of the holders of currently
outstanding Common Stock of the Company, except for effects incidental to
increasing the number of shares of the Company's Common Stock outstanding,
such as dilution of the earnings per share and voting rights of current
holders of Common Stock. If the amendment is adopted, it will become
effective upon filing of a Certificate of Amendment of the Company's Amended
and Restated Certificate of Incorporation with the Secretary of State of the
State of Delaware, a form of which is attached hereto as Exhibit A.

     In addition to the 18,615,969 shares of Common Stock outstanding at
April 26, 2000, as of April 26, 2000, the Board had reserved (i) 1,217,963
shares for issuance upon exercise of outstanding options granted and
heretofore unexercised under the Company's Employee Stock Participation Plan;
(ii) 173,413 shares for issuance upon exercise of options granted under the
1996 Non-Employee Director Stock Option Plan; and (iii) 378,094 shares for
issuance upon exercise of options granted under the 1997 Equity Incentive
Plan, as amended. Therefore, after accounting for such reserves, and taking
into account the shares reserved for issuance under the Company's Preferred
Share Purchase Rights Plan, the Company currently has no additional shares of
Common Stock available for issuance.

     The Board desires to have additional authorized shares for future
business and financial purposes. The additional shares may be used, without
further stockholder approval, for various purposes including, without
limitation, stock dividends to existing stockholders, raising capital,
providing equity incentives to employees, officers or directors, establishing
certain strategic relationships with other companies and expanding the
Company's business or product lines through certain acquisitions of other
businesses or products.

     The additional shares of Common Stock that would become available for
issuance if this proposal were adopted could also be used by the Company to
oppose a hostile takeover attempt or delay or prevent changes in control or
management of the Company. For example, without further stockholder approval,
the Board could sell shares of Common Stock in a private transaction to
purchasers who would oppose a takeover or favor the current Board. Although
this proposal to increase the authorized Common Stock has been prompted by
business and financial considerations and not by the threat of any known or
threatened hostile takeover attempt, stockholders should be aware that
approval of this proposal could facilitate future efforts by the Company to
deter or prevent changes in control of the Company, including transactions in
which the stockholders might otherwise receive a premium for their shares
over then current market prices.

     The affirmative vote of the holders of a majority of the outstanding
shares of the Common Stock will be required to approve this amendment to the
Company's Amended and Restated Certificate of Incorporation. As a result,
abstentions and broker non-votes will have the same effect as negative votes.

     The Board of Directors recommends a vote in favor of Proposal 1.

<PAGE>

                              SECURITY OWNERSHIP OF
                    CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

         The following table sets forth certain information regarding the
beneficial ownership of the Company's Common Stock as of April 26, 2000:

- - each stockholder who is known by us to own beneficially more than 5% of our
  Common Stock;

- - each of our named executive officers;

- - each of our directors; and

- - all of our directors and executive officers as a group.

     Unless otherwise indicated, to our knowledge, all persons listed below
have sole voting and investment power with respect to their shares of our
Common Stock, except to the extent authority is shared by spouses under
applicable law. Beneficial ownership is determined in accordance with the
rules of the Securities and Exchange Commission. Applicable percentage
ownership is based on 18,615,969 shares of common stock outstanding as of
April 26, 2000, together with options for that stockholder that are currently
exercisable or exercisable within 60 days of April 26, 2000. In computing the
number and percentage of shares beneficially owned by a person, shares of
common stock subject to options currently exercisable, or exercisable within
60 days of April 26, 2000 are counted as outstanding, while these shares are
not counted as outstanding for computing the percentage ownership of any
other person.

<TABLE>
<CAPTION>
                                                                          BENEFICIAL OWNERSHIP (1)
                                                                       -------------------------------
                                                                        NUMBER OF           PERCENT OF
BENEFICIAL OWNER                                                         SHARES               TOTAL
- ----------------                                                       -----------          ----------
<S>                                                                    <C>                  <C>
Morgan Stanley Dean Witter (2)......................................     1,036,751             5.6%
   1585 Broadway
   New York, NY  10036
David L. Babson and Company Incorporated (3)........................     1,003,200             5.4%
  One Memorial Drive
  Cambridge, MA  02142-1300
Stephen W. Michael (4)..............................................       128,272                *
Thomas R. Melendrez (4).............................................       115,659                *
Roubik Gregorian (4) ...............................................       103,714                *
Raimon L. Conlisk (4) ..............................................        58,638                *
James E. Dykes (4) .................................................        55,567                *
Frank P. Carrubba (4) ..............................................        15,000                *
Ronald W. Guire(4) .................................................        14,133                *
Donald L. Ciffone, Jr...............................................        12,585                *
Richard Previte (4).................................................           112                *
All executive officers and directors as a group
  (13 persons) (4) .................................................       714,245             3.8%
</TABLE>

* Represents beneficial ownership of less than one percent of the common stock.

(1)      This table is based upon information supplied by officers, directors,
         and principal stockholders and Schedules 13G filed with the Securities
         and Exchange Commission (the "SEC").

(2)      Based on a Schedule 13G filed with the SEC on February 25, 2000.
         Includes 1,015,901 shares over which Morgan Stanley Dean Witter has
         shared voting power and 1,036,751 shares over which Morgan Stanley Dean
         Witter has shared dispositive power.

<PAGE>

(3)      Based on a Schedule 13G filed with the SEC on January 27, 2000.

(4)      Includes shares which certain executive officers and directors have the
         right to acquire within 60 days after April 26, 2000, pursuant to
         outstanding options as follows: Stephen W. Michael, 116,998 shares;
         Thomas R. Melendrez, 74,294 shares; Roubik Gregorian, 102,375 shares;
         Raimon L. Conlisk, 57,138 shares; James E. Dykes, 45,517 shares; Frank
         P. Carrubba, 15,000 shares; Ronald W. Guire, 5,625 shares; Richard
         Previte, 112 shares; and all executive officers and directors as a
         group, 576,585 shares.


                                  OTHER MATTERS

         The Board of Directors knows of no other matters that will be presented
for consideration at the Special Meeting. If any other matters are properly
brought before the meeting, it is the intention of the persons named in the
accompanying proxy to vote on such matters in accordance with their best
judgment.


<PAGE>

         The Board of Directors hopes that stockholders will attend the
meeting. Whether or not you plan to attend, you are urged to complete, sign
and return the enclosed proxy in the accompanying envelope. A prompt response
will greatly facilitate arrangements for the meeting, and your cooperation
will be appreciated. Stockholders who attend the meeting may vote their
shares personally even though they have sent in their proxies.

                                           By Order of the Board of Directors

                                           DONALD L. CIFFONE, JR.
                                           PRESIDENT AND CHIEF EXECUTIVE OFFICER

May __, 2000


<PAGE>

                                                                     EXHIBIT A

                            CERTIFICATE OF AMENDMENT
                                     OF THE
                              AMENDED AND RESTATED
                          CERTIFICATE OF INCORPORATION
                                       OF
                                EXAR CORPORATION

     EXAR CORPORATION, a corporation organized and existing under and by
virtue of the General Corporation Law of the state of Delaware, does hereby
certify:

     FIRST: The name of the corporation is Exar Corporation.

     SECOND: The date on which the Certificate of Incorporation of the
corporation was filed with the Secretary of State of the State of Delaware
was October 10, 1991. An Amended and Restated Certificate of Incorporation
was filed with the Secretary of State of the State of Delaware on February
27, 1992. A Certificate of Amendment and Amended and Restated Certificate of
Incorporation of the corporation was filed with the Secretary of State of the
State of Delaware on January 19, 1995.

     THIRD: The Board of Directors of the corporation, acting in accordance
with the provisions of Section 242 of the General Corporation Law of the
State of Delaware, adopted resolutions to amend the Amended and Restated
Certificate of Incorporation of the corporation by deleting the first
paragraph of Article IV and substituting therefor a new first paragraph of
Article IV in the following form:

          "This corporation is authorized to issue two classes of stock to be
     designated, respectively, `Common Stock' and `Preferred Stock.' The total
     number of shares which the corporation is authorized to issue is one
     hundred two million two hundred fifty thousand (102,250,000) shares. One
     hundred million (100,000,000) shares shall be Common Stock, and two million
     two hundred fifty thousand (2,250,000) shares shall be Preferred Stock,
     each having a par value of one-hundredth of one cent ($.0001)."

     FOURTH: Thereafter, pursuant to a resolution of the Board of Directors,
this Certificate of Amendment was submitted to the stockholders of the
corporation for their approval and was duly adopted in accordance with the
provision of Section 242 of the General Corporation Law of the State of
Delaware.

     IN WITNESS WHEREOF, Exar Corporation has caused this Certificate of
Amendment to be signed by its President and Chief Executive Officer and
attested to by its Secretary this ____ day of _________, 2000.

                                          EXAR CORPORATION

                                          ------------------------------------
                                          Donald L. Ciffone, Jr.
                                          PRESIDENT AND CHIEF EXECUTIVE OFFICER

ATTEST:

- -------------------------------
Ronald W. Guire
SECRETARY

<PAGE>

FORM OF PROXY

                                EXAR CORPORATION

      PROXY SOLICITED BY THE BOARD OF DIRECTORS FOR THE SPECIAL MEETING OF
                    STOCKHOLDERS TO BE HELD ON JUNE 8, 2000

         The undersigned hereby appoints Donald L. Ciffone, Jr. and Ronald W.
Guire and each of them, as attorneys and proxies of the undersigned, with full
power of substitution, to vote all of the shares of stock of Exar Corporation,
which the undersigned may be entitled to vote at the Special Meeting of
Stockholders of Exar Corporation to be held at 48720 Kato Road, Fremont, CA
94538 on June 8, 2000 at 3:00 p.m. (local time), and at any and all
postponements, continuations and adjournments thereof, with all powers that the
undersigned would possess if personally present, upon and in respect of the
following matters and in accordance with the following instructions, with
discretionary authority as to any and all other matters that may properly come
before the meeting.

   UNLESS A CONTRARY DIRECTION IS INDICATED, THIS PROXY WILL BE VOTED FOR THE
  PROPOSAL, AS MORE SPECIFICALLY DESCRIBED IN THE PROXY STATEMENT. IF SPECIFIC
  INSTRUCTIONS ARE INDICATED, THIS PROXY WILL BE VOTED IN ACCORDANCE THEREWITH.

                   (Continued and to be signed on other side)

                              FOLD AND DETACH HERE

<PAGE>

                                 Please mark [ ]
                                    your vote
                                  as indicated

      THE BOARD OF DIRECTORS RECOMMENDS A VOTE FOR THE FOLLOWING PROPOSAL.

PROPOSAL: To approve an amendment to the Company's Amended and Restated
Certificate of Incorporation to increase the authorized number of shares of
Common Stock from 25,000,000 shares to 100,000,000 shares.

                         [ ] FOR [ ] AGAINST [ ] ABSTAIN

    PLEASE VOTE, DATE AND PROMPTLY RETURN THIS PROXY IN THE ENCLOSED RETURN
       ENVELOPE WHICH IS POSTAGE PREPAID IF MAILED IN THE UNITED STATES.

DATED               , 2000
      --------------        ----------------------------------------------
                                    SIGNATURE(S)

                                    Please sign exactly as your name appears
                                    hereon. If the stock is registered in the
                                    names of two or more persons, each should
                                    sign. Executors, administrators, trustees,
                                    guardians and attorneys-in-fact should add
                                    their titles. If signer is a corporation,
                                    please give full corporate name and have a
                                    duly authorized officer sign, stating title.
                                    If signer is a partnership, please sign in
                                    partnership name by authorized person.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission